Total trials
95
Active
14
Phase 3
4
Total enrollment
257,530
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Maltodextrin solution | — | — | — | — | — | 1 | |
| Fecal Microbiota Transplantation | — | — | — | — | — | 1 |
Next readouts
- 2026-12-01
- 2029-12
Top conditions
- Frailty6
- Quality of Life6
- Rectal Cancer5
- Low Anterior Resection Syndrome4
- Old Age4
- Emergencies4
- Surgery3
- Neurocognitive Disorders3
Frequently asked questions about Jewish General Hospital
- How many clinical trials does Jewish General Hospital have on ClinicalTrials.gov?
- Jewish General Hospital is listed as the lead sponsor on 95 clinical trials in ClinicalTrials.gov, 14 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Jewish General Hospital's trials are in Phase 3?
- 4 of Jewish General Hospital's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Jewish General Hospital focus on?
- Jewish General Hospital's most-studied conditions on ClinicalTrials.gov are Frailty, Quality of Life, Rectal Cancer, Low Anterior Resection Syndrome, Old Age.
- When are Jewish General Hospital's next clinical trial readouts?
- Jewish General Hospital has 2 upcoming primary-completion readouts tracked here; the soonest is “Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery”, expected around 2026-12-01.